Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tenaya Therapeutics, Inc. | 120,000 | reported | 28 May 2026 | tx 6+330,427 |
| Ultragenyx Pharmaceutical Inc. | 95,715 | reported | 16 Apr 2026 | tx 94+608,328−219,424 |
| Evolus, Inc. | 77,742 | reported | 17 Feb 2026 | tx 14+207,221−24,819 |
| Anebulo Pharmaceuticals, Inc. | 30,425 | reported | 21 Apr 2022 | tx 1+30,425 |
| Arcturus Therapeutics Holdings Inc. | 15,000 | reported | 18 Jun 2021 | tx 4+65,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 28,895 | 0.00 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 49,960 | 0.00 USD | deriv |
| 10 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 3,508 | 22.67 USD | |
| 06 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 6,018 | 21.40 USD | |
| 01 Mar 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 11,137 | 0.00 USD | |
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 8,135 | 22.80 USD | |
| 17 Feb 2026 | GRANT_AWARD | Evolus, Inc. | 45,559 | 0.00 USD | |
| 12 Sept 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 2,450 | 31.17 USD | |
| 29 May 2025 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 107,400 | 0.00 USD | deriv |
| 12 Mar 2025 | SALE | Evolus, Inc. | 12,888 | 12.99 USD | |
| 07 Mar 2025 | GRANT_AWARD | Evolus, Inc. | 7,364 | 0.00 USD | |
| 07 Mar 2025 | GRANT_AWARD | Evolus, Inc. | 11,146 | 0.00 USD | deriv |
| 03 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 12,846 | 42.10 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 18,443 | 0.00 USD | |
| 27 Feb 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 2,230 | 42.93 USD | |
| 27 Feb 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 760 | 42.75 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,494 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 26,074 | 0.00 USD | deriv |
| 18 Oct 2024 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 34,000 | 0.00 USD | deriv |
| 12 Jun 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 9,806 | 45.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 957 | 0.00 USD | |
| 01 Mar 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 3,756 | 53.76 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 17,800 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 31,400 | 0.00 USD | deriv |